|
|
|
|
President's Message
Prof. Heather Wallace
EUROTOX President
With the annual congress behind us I look back on the ever increasing success of our EUROTOX Congresses. The 55th Congress of the European Societies of Toxicology, EUROTOX 2019, held recently in the beautiful city of Helsinki was, I believe, one of the most successful to date. It was a truly international Congress with more than 1600 delegates from 63 countries. The carefully crafted scientific programme was inclusive and the industry sessions added value to the congress. The social programme was also a great success and a special thanks to the City of Helsinki who hosted us at the City Hall on Monday evening. Such success takes hard work and effort and I thank the Finnish Society of Toxicology for hosting this great event. A special thanks also to Professor Kai Savolainen from the Finnish Institute of Occupational Health, ably assisted by Dr David Bell from ECHA for their excellent organisation and planning. Looking forward, EUROTOX 2020 will be held in Copenhagen, September 6-9, 2020, and I invite you all to participate in our next congress.
EUROTOX is undertaking a project to map the training of toxicologists across Europe, and I ask everyone to try to help by sending comments and participating in our employers survey.
The Executive Committee is continuing to progress the concept of the EUROTOX Faculty and details on how to help will be released soon.
EUROTOX is now part of the Scientific Liaison Coalition (SLC) giving us access to webinars and training opportunities worldwide.
The call for proposals for scientific sessions at EUROTOX 2021 in Ljubljana will be open soon and I encourage you to submit your ideas for innovative and exciting scientific symposia and workshops and become part of the ever growing EUROTOX family.
|
|
Job Posting
PROJECT TOXICOLOGIST IN ONCOLOGY
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceutical and the supply of healthcare services. An exciting opportunity exists for a talented Project Toxicologist to join us to support the development of innovative Oncology drugs and restore patients’ lives. The position is based in Cambridge, UK.
TO LEARN MORE
TO APPLY ONLINE
 PhD OPPORTUNITY
Amsterdam Rheumatology Center for AutoImmune Diseases (ARCAID) is looking for 2 international PhD students (project 4 years) for their EU Horizon 2020 COFUND project. The entire project has 20 PhD vacancies. A human gut and -lymphatics on chip to model functional immune surveillance and activation:
PhD1: development of immune competent gut on chip model
PhD2: development of immune competent lymph node on chip model including lymph node stromal cells, lymphocytes, and dendritic cells.
See link for more info and how to apply
|
|
 The recorded webinar "Health Hazards of Electronic Cigarettes" held September 17, 2019, presented by Neal L. Benowitz MD, Professor Emeritus of Medicine, University of California San Francisco is now available online.
The impact of electronic cigarette use on population health is strongly influenced by the harms and risks of e-cigarettes. The harm from cigarette smoking is to a great extent caused by toxic products of tobacco combustion. E-cigarettes deliver nicotine in an inhalable aerosol without combustion. E-cigarettes do deliver propylene glycol, vegetable glycerin, various flavoring chemicals and their various thermal breakdown products, as well as particles; some of these chemicals are potentially toxic. E-cigarettes vary considerably in design, and the risk is almost certainly greater with those with bigger batteries that operate at higher temperatures. The long-term safety of e-cigarettes is unknown at this time. Major current health concerns in the U.S. relate to e-cigarette use by youth, particularly with respect to impaired adolescent brain development, development of nicotine addiction and serving as a gateway to cigarette and other drug use. Short-term adverse effects include increased respiratory symptoms and asthma, although in smokers with chronic lung disease who switch completely to e-cigarettes their respiratory symptoms improve. Other health concerns include cardiovascular toxicity (particularly in people with pre-existing heart disease) and reproductive toxicity during pregnancy. Direct nicotine toxicity from ingestion of nicotine-containing liquids can occur, particularly in children, but is uncommon.
To listen to the recorded e-cigarettes webinar (use the scroll bar to the right to play the various sections of the webinar)
The next SLC webinar is scheduled for February 11, 2020, and will feature Dr. Rich Miller. Linda Roberts is coordinating this webinar as part of her work on the SLC’s Occupational Exposures Working Group. |
|
|
|
|
|
|
|
EUROTOX fellowship program for ERT courses comes to an end
